In 1999, results from the Multimodal Treatment for ADHD (MTA) study - the most comprehensive study of treatment strategies for ADHD ever undertaken - were published explaining that for children with attention deficit...
- Mental Illnesses
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are hereDiscoveries ›
Next Generation Therapies
Scientific Council Member, Jeffrey A. Lieberman, M.D. of Columbia University Medical Center presents an overview of the current state of mental healthcare, offering specific recommendations on how to continue to improve...
In 1989 NARSAD Distinguished Investigator and Foundation Scientific Council member, Herbert Y. Meltzer, M.D., proved that the drug Clozapine(tm) can be used on patients with severe treatment-resistant schizophrenia....
An Impressive Year of Progress: from establishing early intervention techniques and working toward diagnostic tools, to proving the effectiveness of next generation therapies, to advancing basic research and our...
Recent research has shown that children as young as 3 years old can experience symptoms of clinical depression. Research has also shown that half of all cases of depression arise during childhood. While evidence suggests...